Ancora Advisors’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

Ancora Advisors’s Portfolio RCKTW Stock Details RCKTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22	Hold	6,000	–	–	﹤0.01%	1962
2026 Q1	$124	Hold	6,000	–	–	﹤0.01%	2348
2025 Q4	$146	Hold	6,000	–	–	﹤0.01%	2378
2025 Q3	$235	Hold	6,000	–	–	﹤0.01%	1892
2025 Q2	$204	Hold	6,000	–	–	﹤0.01%	1897
2025 Q1	$282	Hold	6,000	–	–	﹤0.01%	1672
2024 Q4	$206	Hold	6,000	–	–	﹤0.01%	1732
2024 Q3	$433	Hold	6,000	–	–	﹤0.01%	1641
2024 Q2	$364	Hold	6,000	–	–	﹤0.01%	1726
2024 Q1	$1.79K	Hold	6,000	–	–	﹤0.01%	1567
2023 Q4	$2.94K	Hold	6,000	–	–	﹤0.01%	1446
2023 Q3	$1.02K	Hold	6,000	–	–	﹤0.01%	1565
2023 Q2	$1.14K	Hold	6,000	–	–	﹤0.01%	1551
2023 Q1	$785	Buy	+6,000	New	+$1.16K	﹤0.01%	1657

Other funds holding RCKTW

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Ancora Advisors's RCKTW Position: Q2 2026 in Review

Ancora Advisors held its Rocket Pharmaceuticals Warrant (RCKTW) position steady in Q2 2026 at 6,000 shares worth $22. The position accounts for ﹤0.01% of the portfolio, ranked #1962.

Ancora Advisors first reported a position in RCKTW in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.94K in Q4 2023. 11 funds tracked by Wall St. Rank hold RCKTW as of Q2 2026.

Ancora Advisors held 6,000 shares of Rocket Pharmaceuticals Warrant worth $22 as of Q2 2026.
Ancora Advisors left its Rocket Pharmaceuticals Warrant share count unchanged in Q2 2026.
Rocket Pharmaceuticals Warrant made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #1962 holding.
Ancora Advisors first reported a position in Rocket Pharmaceuticals Warrant in Q1 2023 and has held it in 14 quarters since.
Ancora Advisors's Rocket Pharmaceuticals Warrant position peaked at $2.94K in Q4 2023.
11 funds tracked by Wall St. Rank held Rocket Pharmaceuticals Warrant as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.